Related Experiment Video

Updated: Aug 13, 2026

A Simplified Method for Isolation and Culture of Retinal Pigment Epithelial Cells from Adult Mice
05:04

A Simplified Method for Isolation and Culture of Retinal Pigment Epithelial Cells from Adult Mice

Published on: May 24, 2024

Inhibition of human retinal pigment epithelial cell attachment, spreading, and migration by alkylphosphocholines

Kirsten H Eibl1, Daniel Kook, Siegfried Priglinger

  • 1Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany.

Investigative Ophthalmology & Visual Science
|December 31, 2005
PubMed
Abstract

Insights

Alkylphosphocholines (APCs) significantly inhibit retinal pigment epithelium (RPE) cell attachment, spreading, and migration in vitro. These compounds disrupt microfilament assembly, offering a potential therapeutic strategy for proliferative vitreoretinal diseases.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Biochemistry

Background:

  • Retinal pigment epithelium (RPE) cells are crucial for retinal health.
  • Proliferative vitreoretinal diseases, such as proliferative vitreoretinopathy (PVR), involve aberrant RPE cell behavior.
  • Understanding factors affecting RPE cell function is vital for developing treatments.

Purpose of the Study:

  • To investigate the in vitro effects of alkylphosphocholines (APCs) on human RPE cell attachment, spreading, migration, and microfilament organization.
  • To assess the potential of APCs as a therapeutic intervention for RPE-related retinal diseases.

Main Methods:

  • Human RPE cells from five donors were cultured and treated with four different APCs (C18:1-PC, C20:1-PC, C21:1-PC, C22:1-PC).
  • Cell viability was assessed using the trypan blue exclusion assay.
  • Attachment, spreading, and migration were quantified using MTT assays, direct cell counting, and modified Boyden chamber methods, respectively.
  • Microfilament assembly was analyzed via immunofluorescence staining with rhodamine-phalloidin.

Main Results:

  • All four tested APCs significantly inhibited RPE cell attachment (over 70% inhibition at IC50 concentrations).
  • APCs markedly reduced RPE cell spreading (over 80%) and migration (over 90%) at similar concentrations.
  • Microfilament organization was notably disturbed in RPE cells treated with APCs near their IC50, without significant toxicity.

Conclusions:

  • Alkylphosphocholines effectively inhibit human RPE cell attachment and spreading in vitro at non-toxic concentrations.
  • APCs appear to exert their effects by disrupting microfilament assembly, potentially through interference with protein kinase C (PKC) pathways.
  • These findings suggest APCs could offer a novel therapeutic approach for managing early stages of proliferative vitreoretinal diseases like PVR.

More Related Videos

Experimental Models for Study of Retinal Pigment Epithelial Physiology and Pathophysiology08:28

Experimental Models for Study of Retinal Pigment Epithelial Physiology and Pathophysiology

Published on: November 6, 2010

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...